Miraculins Announces Completion of PREVU Skin Cholesterol Test Acquisition
Miraculins Announces Completion of PREVU Skin Cholesterol Test Acquisition
WINNIPEG, MANITOBA– – Miraculins Inc. , a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, is pleased to announce that it has completed the acquisition from PreMD Inc. of all assets relating to the PREVU Skin Cholesterol Test.
Read more on CCNMatthews via Yahoo! Finance